Electromed Cost Of Revenue from 2010 to 2024

ELMD Stock  USD 16.73  0.34  2.07%   
Electromed's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Overall, Cost Of Revenue is expected to go to about 13.9 M this year. During the period from 2010 to 2024 Electromed Cost Of Revenue annual values regression line had geometric mean of  6,688,516 and mean square error of 1.6 T. View All Fundamentals
 
Cost Of Revenue  
First Reported
2008-06-30
Previous Quarter
2.8 M
Current Value
3.1 M
Quarterly Volatility
623 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Electromed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Electromed main balance sheet or income statement drivers, such as Depreciation And Amortization of 669.7 K, Interest Expense of 85.2 K or Selling General Administrative of 38.2 M, as well as many exotic indicators such as Price To Sales Ratio of 1.35, Dividend Yield of 0.0345 or PTB Ratio of 2.63. Electromed financial statements analysis is a perfect complement when working with Electromed Valuation or Volatility modules.
  
This module can also supplement Electromed's financial leverage analysis and stock options assessment as well as various Electromed Technical models . Check out the analysis of Electromed Correlation against competitors.
For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.

Latest Electromed's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Electromed over the last few years. Cost of Revenue is found on Electromed income statement and represents the costs associated with goods and services Electromed provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Electromed's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Electromed's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Electromed Cost Of Revenue Regression Statistics

Arithmetic Mean7,417,118
Geometric Mean6,688,516
Coefficient Of Variation46.14
Mean Deviation2,718,601
Median5,841,601
Standard Deviation3,422,380
Sample Variance11.7T
Range11.8M
R-Value0.93
Mean Square Error1.6T
R-Squared0.87
Slope715,350
Total Sum of Squares164T

Electromed Cost Of Revenue History

202413.9 M
202313.3 M
202211.5 M
202110.2 M
20208.5 M
20197.3 M
20187.5 M

About Electromed Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Electromed income statement, its balance sheet, and the statement of cash flows. Electromed investors use historical funamental indicators, such as Electromed's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Electromed investors may use each financial statement separately, they are all related. The changes in Electromed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Electromed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Electromed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Electromed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue13.3 M13.9 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Electromed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Electromed's short interest history, or implied volatility extrapolated from Electromed options trading.

Pair Trading with Electromed

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromed will appreciate offsetting losses from the drop in the long position's value.

Moving together with Electromed Stock

  0.76HQY HealthEquity Financial Report 3rd of June 2024 PairCorr

Moving against Electromed Stock

  0.71RSLS ReShape LifesciencesPairCorr
  0.68HSDT Helius Medical Techn Financial Report 9th of May 2024 PairCorr
  0.64BBLG Bone Biologics Corp Financial Report 20th of May 2024 PairCorr
  0.62HCAT Health Catalyst Upward RallyPairCorr
  0.58SINT SINTX TechnologiesPairCorr
The ability to find closely correlated positions to Electromed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromed to buy it.
The correlation of Electromed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:
Check out the analysis of Electromed Correlation against competitors.
For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Electromed Stock analysis

When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.727
Earnings Share
0.45
Revenue Per Share
6.072
Quarterly Revenue Growth
0.167
Return On Assets
0.0721
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.